Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Tax Provisions: 2012-2025

Historic Tax Provisions for CorMedix (CRMD) over the last 1 years, with Sep 2025 value amounting to -$56.0 million.

  • CorMedix's Tax Provisions fell 1070593.35% to -$56.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.4 million, marking a year-over-year decrease of 2544.87%. This contributed to the annual value of -$1.4 million for FY2024, which is 192.98% down from last year.
  • CorMedix's Tax Provisions amounted to -$56.0 million in Q3 2025, which was down 1,070,593.35% from $5,230 recorded in Q3 2024.
  • In the past 5 years, CorMedix's Tax Provisions registered a high of $5,230 during Q3 2024, and its lowest value of -$56.0 million during Q3 2025.
  • For the 2-year period, CorMedix's Tax Provisions averaged around -$14.3 million, with its median value being -$700,000 (2024).
  • Data for CorMedix's Tax Provisions shows a maximum YoY plummeted of 1,070,593.35% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows CorMedix's Tax Provisions stood at $5,230 in 2024, then tumbled by 1,070,593.35% to -$56.0 million in 2025.
  • Its last three reported values are -$56.0 million in Q3 2025, $5,230 for Q3 2024, and -$5,230 during Q2 2024.